GLP-1 Receptor Agonists in 2026: Manufacturing, Market Access, and Strategic Challenges in the Semaglutide Era
A comprehensive analysis of semaglutide’s evolving role in the GLP-1 landscape, including manufacturing complexity, regulatory pathways, and market dynamics.

